Controlled/modified release oral methylphenidate formulations

(19)

(11)

EP 1 967 191 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	20.07.2016 Bulletin 2016/29

(45)	Mention of the grant of the patent:
	18.05.2016 Bulletin 2016/20

(21)	Application number: 08156397.5

(22)	Date of filing: 17.12.1999

(51)

International Patent Classification (IPC):

A61K 9/16^(2006.01)

(54)	Controlled/modified release oral methylphenidate formulations Orale Methylphenidat-Formulierungen mit kontrollierter/veränderter Freisetzung Formulations orales de methylphenidate a liberation regulee/modifiee

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

17.12.1998 US 112667 P

(43)	Date of publication of application:
	10.09.2008 Bulletin 2008/37

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	99967438.5 / 1140088

(73)	Proprietor: EURO-CELTIQUE S.A.
	2350 Luxembourg (LU)

(72)	Inventors:
	Goldenheim, Paul D. Cambridge, MA 02140-3616 (US) Sackler, Richard S. Greenwich, CT 06830 (US) Krishnamurthy, Thinnayam N. Pickering Ontario L1W 3W8 (CA) Darke, Andrew Pickering Ontario L1W 3W8 (CA) Oshlack, Benjamin Boca Raton, FL 33432 (US)

(74)	Representative: Glas, Holger
	Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München 80335 München (DE)

(56)

References cited: :

WO-A-97/03673
US-A- 5 286 493

WO-A-98/23263
US-A- 5 837 284

DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 30 October 1997 (1997-10-30), ERRAMOUSPE, JOHN ET AL: "Effect on dissolution from halving methylphenidate extended -release tablets" XP002489744 retrieved from STN Database accession no. 1997:686114 & ANNALS OF PHARMACOTHERAPY , 31(10), 1123-1126 CODEN: APHRER; ISSN: 1060-0280, 1997,

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).